6 Combat HIV/AIDS, malaria and other diseases

Where we are?

MDG 6 Kazakhstan
Kazakhstan has identified the fight against TB and HIV/AIDS as one of the major priorities in its Development Strategy.

Target 7. To halt, by 2015, and begin to reverse the spread of HIV/AIDS

As at 1 January 2010, there were 13,784 cases of HIV infection registered in the Republic of Kazakhstan. Since 1987, there has been an increase in new HIV infection cases every year other than 2009. The HIV incidence rate among population aged 15-49 is 0.15 percent. As before, intravenous drug use is a dominant transmission mode accounting for 67.5 percent of cases, with sexual transmission accounting for 24.4 percent. HIV infection is concentrated among injection drug users (incidence rate is 2.9 percent). The situation analysis shows that though Kazakhstan does manage to restrain the HIV epidemic at its initial stage (HIV is concentrated primarily among injection drug users), there remains the possibility for deterioration. This is because the behaviour practiced, in the first instance, by drug injectors is not safe, the level of awareness of young people about HIV transmission modes and ways to avoid HIV infection is not always sufficient and access to treatment is not secured in full. Despite significant progress in combating the HIV epidemic, the following efforts need to be reinforced in order to achieve the target:

- The strengthening political commitment to HIV and AIDS;

- Providing access to ARV therapy for all patients in need;

- Raising of youth awareness;

- Ensuring sustainable prevention programmes for the most vulnerable groups;

- Further improvement of the epidemiologic tracking system;

- The strengthening of cooperation with NGOs.

Targets for MDG6
  1. Halt and begin to reverse the spread of HIV/AIDS
    • HIV prevalence among population aged 15-24 years
    • Condom use at last high-risk sex
    • Proportion of population aged 15-24 years with comprehensive correct knowledge of HIV/AIDS
    • Ratio of school attendance of orphans to school attendance of non-orphans aged 10-14 years
  2. Achieve, by 2010, universal access to treatment for HIV/AIDS for all those who need it
    • Proportion of population with advanced HIV infection with access to antiretroviral drugs